In this study, we identify USP21 as a novel upstream regulator which interacts with and stabilizes FOXD1 and show that genetic or pharmacological inhibition of USP21 abrogates MES GSC-derived tumor growth in vitro and in vivo by antagonizing FOXD1 ubiquitination and degradation. Here, FOXD1 is linked to neoplasm.